Opinion Piece Touts Bill Differentiating Biosimilars

In a Capitol Weekly opinion piece, Gerald Felando -- a dentist and a former Assembly member -- writes that legislation (SB 598) that would require pharmacists to notify physicians when biosimilar drugs are substituted for advanced biologic medications would "ensure patient safety across California." According to Felando, "Leaving patients and physicians in the dark as to when a substitution occurs is spinning the health care roulette wheel" and could endanger patients' health and safety.

• "In Search of Affordable Health Care" (Felando, Capitol Weekly, 4/25).